NASDAQ: QUCY
Mainz Biomed Nv Stock Ownership - Who owns Mainz Biomed Nv?

Insider buying vs selling

Have Mainz Biomed Nv insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin Michael Donahue10% Owner2025-10-17643,850$0.62
$399.19kBuy
Kevin Michael Donahue10% Owner2025-10-17643,850$0.62
$399.19kBuy
Kevin Michael Donahue10% Owner2025-10-17685,000$1.51
$1.03MBuy

1 of 1

QUCY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when QUCY insiders and whales buy or sell their stock.

QUCY Shareholders

What type of owners hold Mainz Biomed Nv stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC6.19%775,263$368.25kInstitution
Kevin Michael Donahue5.47%685,000$325.38kInsider
Guido Baechler4.83%605,058$287.40kInsider
William J. Caragol2.94%367,899$174.75kInsider
Cerity Partners LLC1.30%163,253$77.55kInstitution
Heinrich 1. Dreismann0.52%64,700$30.73kInsider
Gregory J. Tibbitts0.45%55,875$26.54kInsider
Ubs Group Ag0.43%54,181$25.74kInstitution
Hans Hekland0.36%45,000$21.38kInsider
Corient Private Wealth LLC0.32%40,000$19.00kInstitution

1 of 3

QUCY vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QUCY9.20%14.57%Net Buying
NDRA5.33%94.67%Net Buying
ADVB4.08%0.00%
ISPC0.43%21.77%
NOTV22.01%39.39%Net SellingNet Selling

Mainz Biomed Nv Stock Ownership FAQ

Who owns Mainz Biomed Nv?

Mainz Biomed Nv (NASDAQ: QUCY) is owned by 9.20% institutional shareholders, 14.57% Mainz Biomed Nv insiders, and 76.23% retail investors. Kevin Michael Donahue is the largest individual Mainz Biomed Nv shareholder, owning 685,000.00 shares representing 5.47% of the company. Kevin Michael Donahue's Mainz Biomed Nv shares are currently valued at $331.54k.

If you're new to stock investing, here's how to buy Mainz Biomed Nv stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.